An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

A new study has found that an experimental drug appears to reduce the risk of Alzheimer’ s-related dementia in people ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

The anti-amyloid therapy gantenerumab lowered the chances for developing Alzheimer’s-related dementia in people at high risk for the disease, according to a small study conducted by the Knight Family ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky ...

The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight ...